Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Clinical Trials

Clinical Trials at The Methodist Hospital Research Institute

Search results...

Respiratory Tract (Lung and Bronchial) Diseases

Active and enrolling clinical trials for Respiratory Tract (Lung and Bronchial) Diseases are updated on this page as they become available. You are also welcome to view our clinical trials that are registered with the National Institutes of Health.
 
For more information please contact the study coordinator of the trials listed below or contact the main clinical trials help line 713-441-3250.
 
Lung Cancers

CA216.001 BMS906024 in Subjects With Advanced or Metastatic Solid Tumor
Study Status: Active/Enrolling
Investigator: Iyer, Swaminathan
Study Coordinator: Logan, Catherine
Phone: 713-441-0629
Summary:The purpose of this study is to identify a safe and tolerable dose of BMS-906024 in subjects with advanced or metastatic solid tumors who no longer respond to or have relapsed from standard therapies.(read more)

GALAXY 2 TRIAL Ganetespib w/Docetaxel vs Docetaxel alone in patients w/advanced NSCLC
Study Status: Active/Enrolling
Investigator: Bernicker, Eric
Study Coordinator: Bieniemy, Dana
Phone: 713-441-0629
Summary:The purpose of this study is to determine whether combining ganetespib (STA-9090) with docetaxel is more effective than docetaxel alone in the treatment of patients with advanced non-small cell lung c...(read more)

LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
Study Status: Active/Enrolling
Investigator: Bernicker, Eric
Study Coordinator: Bieniemy, Dana
Phone: 713-441-0629
Summary:The primary purpose of the study is to compare the antitumor activity of LDK378 vs. chemotherapy in patients previously treated with chemotherapy (platinum doublet) and crizotinib.(read more)

OAK TRIAL - MPDL3280A with Docetaxel in Patients with Non-Small Cell Lung Cancer After Failure with Platinum-Containing Chemotherapy
Study Status: Active/Enrolling
Investigator: Bernicker, Eric
Study Coordinator: Bieniemy, Dana
Phone: 713-441-0629
Summary:This global, multicenter, open-label, randomized, controlled study will evaluate the efficacy and safety of MPDL3280A compared with docetaxel in patients with locally advanced or metastatic non-small ...(read more)

S0819 Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab w/ or w/out Cetuximab in Patients with NSCLC
Study Status: Active/Enrolling
Investigator: Bernicker, Eric
Study Coordinator: Bieniemy, Dana
Phone: 713-441-0629
Summary:RATIONALE: Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Mono...(read more)